NextScience Decides to Acquire $6.1 Million Worth of Shares in US Biotech Company
[Asia Economy Reporter Geum Bo-ryeong] NextScience announced on the 21st that it has decided to acquire 1 million shares of the US biopharmaceutical development company 'Immunomic Therapeutics, Inc.' for approximately 6.1 billion KRW.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
After acquiring the shares, the equity ratio will be 3.7%. The scheduled date for the stock acquisition is the 23rd.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
